HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An alternative method for estimating efficacy of the AN1792 vaccine for Alzheimer disease.

AuthorsM Grundman, S Gilman, R S Black, N C Fox, M Koller
JournalNeurology (Neurology) Vol. 71 Issue 9 Pg. 697; author reply 697-8 (Aug 26 2008) ISSN: 1526-632X [Electronic] United States
PMID18725601 (Publication Type: Letter, Comment)
Chemical References
  • Antibodies
  • Vaccines
Topics
  • Alzheimer Disease (drug therapy, immunology, physiopathology)
  • Antibodies (analysis, blood)
  • Clinical Trials as Topic (standards)
  • Data Interpretation, Statistical
  • Endpoint Determination (methods, standards)
  • Humans
  • Immunotherapy, Active (methods, standards)
  • Outcome Assessment, Health Care (methods, standards)
  • Placebo Effect
  • Treatment Outcome
  • Vaccines (immunology, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: